Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DA vs DAC in early-stage breast cancer
NCT02838225Phase 2Completed
- Sponsor
- Peking Union Medical College Hospital
- Start
- Jan 2009
- Primary completion
- Jan 2016
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of cyclophosphamide in breast cancer, sponsored by Peking Union Medical College Hospital. Started Jan 2009; status: completed.
02
Drugs
cyclophosphamide
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02838225.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02838225.